Authors: Paridaens, R Biganzoli, L Bruning, P Klijn, JGM Gamucci, T Houston, S Coleman, R Schachter, J Van Vreckem, A Sylvester, R Awada, A Wildiers, J Piccart, M

Citation: R. Paridaens et al., Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European organization for research and treatment of cancer randomized study with cross-over, J CL ONCOL, 18(4), 2000, pp. 724-733